2026-05-20
medium
Sebelius Kathleen
Buy
56,818 shares
$50,000
@ $0.88
Significance
5/10
Director Sebelius buys 56,818 HUMA shares at $0.88 (+62.3% position increase) while stock trades -68.6% from 52-week high.
Director Kathleen Sebelius purchased 56,818 shares at $0.88 on 2026-05-19, increasing her holdings by 62.3% to 148,025 shares. The purchase occurred when the stock was trading at $0.92, currently 68.6% below its 52-week high of $2.93, though up 33.8% over the prior 30 days. Humacyte remains unprofitable with net income of $-17.6M against quarterly revenue of $495.0K, and the company has a market cap of $204.3M. This buy represents a substantial position increase during a period of depressed valuation relative to recent highs.